Lonza Appoints Wolfgang Wienand as New CEO

Tuesday, 2 April 2024, 09:21
In a recent development, Swiss contract drug manufacturer Lonza has named Wolfgang Wienand as its new CEO, taking over from interim CEO Albert Baehny this summer in 2024. This leadership transition signals a significant change in the company's direction and strategy.
https://store.livarava.com/1344a92d-f0d3-11ee-892f-87cc5c87fb08.jpg
Lonza Appoints Wolfgang Wienand as New CEO

Lonza Appoints Wolfgang Wienand as New CEO

Swiss contract drug manufacturer, Lonza, has appointed Wolfgang Wienand as its new CEO, succeeding interim CEO Albert Baehny during summer 2024.

This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.

Newsletter

Get the most reliable and up-to-date financial news with our curated selections. Subscribe to our newsletter for convenient access and enhance your analytical work effortlessly.

Subscribe